DW1026C1

· Daewon Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DW1026C1, covering 2025-07-21 to 2025-07-21. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of DW1026C1 or DW1026C2 [Phase 3]